Merrimack $25 Million Term Loan With Hercules Capital
Reading Time: 2 minutesMerrimack Pharmaceuticals, Inc, a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing of a $25 million term loan with Hercules Capital, $15 million of which was […]
